Analysts’ Updated EPS Estimates for November 18th (CANF, CARS, CWAN, HD, NICE, NNOX, PDD, SIA, SOUN, T)

Analysts’ updated eps estimates for Tuesday, November 18th:

Can-Fite BioPharma (NYSE:CANF) had its buy rating reiterated by analysts at D. Boral Capital. They currently have a $11.00 target price on the stock.

Cars.com (NYSE:CARS) had its buy rating reaffirmed by analysts at DA Davidson. They currently have a $13.50 target price on the stock.

Clearwater Analytics (NYSE:CWAN) had its buy rating reiterated by analysts at DA Davidson. DA Davidson currently has a $30.00 price target on the stock.

Home Depot (NYSE:HD) had its sell rating reiterated by analysts at DZ Bank AG.

Home Depot (NYSE:HD) had its buy rating reiterated by analysts at DA Davidson. DA Davidson currently has a $475.00 price target on the stock.

NiCE (NASDAQ:NICE) had its price target reduced by DA Davidson from $150.00 to $130.00. DA Davidson currently has a neutral rating on the stock.

Nano-X Imaging (NASDAQ:NNOX) had its buy rating reiterated by analysts at D. Boral Capital. They currently have a $8.00 price target on the stock.

PDD (NASDAQ:PDD) was downgraded by analysts at Sanford C. Bernstein from an outperform rating to a market perform rating.

Sienna Senior Living (TSE:SIA) was upgraded by analysts at CIBC from a neutral rating to an outperform rating. CIBC currently has C$23.00 price target on the stock, up from their previous price target of C$20.00.

SoundHound AI (NASDAQ:SOUN) had its buy rating reaffirmed by analysts at DA Davidson. They currently have a $17.00 price target on the stock.

TELUS (TSE:T) (NYSE:TU) was downgraded by analysts at JPMorgan Chase & Co. from a neutral rating to an underweight rating. They currently have C$19.00 price target on the stock, down from their previous price target of C$22.00.

Receive News & Ratings for Can-Fite BioPharma Ltd Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Can-Fite BioPharma Ltd and related companies with MarketBeat.com's FREE daily email newsletter.